Category: Medical Director

Paola-1/ENGOT – OV25 trial

Results from Paola-1 ENGOT/OV25 The October edition of The European Journal of Cancer (EJC) has published “Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial” The results were presented by Dr. Isabelle Ray-Coquard at ESMO – European Society for Medical Oncology in Paris last month. #EuropeanJournalofCancer #EJC #PAOLA #ENGOT #clinicaltrial #ovariancancer #NSGO arrow-icon-size3 Back To […]

OvaCure Challenge

OvaCure Challenge 2022 Our Medical Director, Dr. Mansoor Raza Mirza, had the pleasure of attending the amazing OvaCure – Curing Ovarian Cancer Together Innovation Challenge 2022 event in Copenhagen. Alexander Peitersen, Director of OvaCure, Prof. Robert Bast, VP of Translational Research at MD Andersson Cancer Center – Houston & Dr. Mansoor Raza Mirza, Medical Director […]

World Ovarian Cancer Day

WORLD OVARIAN CANCER DAY Sep. 20th 2022 Today is World Ovarian Cancer Day! Annually, ovarian cancer results in more than 42,700 deaths in Europe. NSGO-CTU is currently involved in 18 Ovarian Cancer Trials in #Denmark, #Sweden, #Norway, #Finland, #Lithuania & #Estonia. See our trial overview with + 30 trials arrow-icon-size3 Back To Overview

Investigator Meeting 2022 – registration is open

Investigator meeting 2022 Copenhagen Registration for the NSGO-CTU Biannual Investigator Meeting in Copenhagen is now open! NSGO-CTU welcomes all members and other professionals with interest in gynaecological cancer research to the NSGO-CTU Biannual Investigator Meeting 24. – 25 of November, 2022 https://nsgo.org/wp-content/uploads/2022/08/Buildings-85277.mp4 arrow-icon-size3 Register Now arrow-icon-size3 Back To Overview It is a long established fact that a […]

ESGO 2022 – soon

ESGO 2022 Our ESGO Vice President, Dr. Mansoor Raza Mirza from the Copenhagen University Hospital will be at ESGO 2022 as an expert speaker! He has broad experience in clinical protocol development, trial conduct and clinical trial regulations. Dr. Mirza is also a senior author of national guidelines for different cancer treatments. Don’t miss his […]

6th OCCC – CGIG

6th OCC – GCIG CONCESUS The consensus recommendation from the GCIG group for “Clinical research in ovarian cancer ” (from the 6th OCC) has been published. Line Bjørge, Mansoor R Mirza and Annika Auranen from NSGO-CTU contributed substantially to the publication. This will represent our guidelines for the upcoming years. #ovariancancer #ovariancanceravareness arrow-icon-size3 Back To Overview

ANNUAL MEETING 2022 – HELSINKI / Gallery

ANNUAL MEETING 2022 – HELSIKI Thank you for a wonderful meeting in Helsinki. Thank you to our speakers: Iain McNeish, Antonio González Martín, Andreas Du Bois, Jalid Sehouli, Usha Menon, Christina Fotopoulou,Domenica Lorusso, Prof. Dr. Frederik Marmé and Roger Strand and many more. On behalf of Prof. Line Bjørge & Dr. Mirza See you in […]

ASCO 2022

ASCO 2022 Dr. Mansoor Raza Mirza and our Project Manager, Mia Sejer Donner attended the wonderful ASCO conference in Chicago 2022. The days where filled with meetings and sessions from dawn till dusk and they both returned to Copenhagen highly inspired. arrow-icon-size3 Back To Overview

Annual Meeting – Helsinki

Annual Meeting 2022 The NSGO Annual Meeting is this year face to face from 30th March 2022 – 1st April 2022 at Hilton Helsinki Kalastajatorppa, Finland. The scientific program of this meeting focuses on Ovarian cancer, and we are honored that the most prominent international faculty is joining our meeting. The program includes Scientific sessions where scientific work will be represented in […]

NSGO & OVACURE

OVACURE AT NSGO-CTU, we pride ourselves in working with top industry collaborators. OvaCure is a non-profit organization that brings together leading researchers across specialties and borders to launch new innovative research that can lead to better treatment of ovarian cancer and ultimately find a cure for women’s cancer. Mansoor Raza Mirza is thus among the […]